Last reviewed · How we verify
[14C]Ulonivirine
At a glance
| Generic name | [14C]Ulonivirine |
|---|---|
| Also known as | [14C]ULO, [14C]MK-8507 |
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [14C]Ulonivirine CI brief — competitive landscape report
- [14C]Ulonivirine updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI